Specify a stock or a cryptocurrency in the search bar to get a summary
CV Sciences Inc
CVSICV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. The company offers its products under the PlusCBD, ProCBD, HappyLane, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California. Address: 9530 Padgett Street, San Diego, CA, United States, 92126
Analytics
WallStreet Target Price
0.05 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CVSI
Dividend Analytics CVSI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CVSI
Stock Valuation CVSI
Financials CVSI
Results | 2019 | Dynamics |